Beam Therapeutics Inc (BEAM) PT Lowered to $40 at Bernstein; 'Shares Still Undervalued'
Tweet Send to a Friend
Bernstein SocGen Group analyst William Pickering lowered the price target on Beam Therapeutics Inc (NASDAQ: BEAM) to $40.00 (from $41.00) ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
